Acne
Latest News
Spironolactone not linked to increased cancer risk in systematic review and meta-analysis
The data are “reassuring,” the authors reported.
Military Dermatology
Oral Isotretinoin for Acne in the US Military: How Accelerated Courses and Teledermatology Can Minimize the Duty-Limiting Impacts of Treatment
We review operational restrictions to acne-specific therapeutics and discuss an accelerated course of oral isotretinoin as a safe and effective...
Latest News
Questions about optimal dosing of isotretinoin persist, expert says
“It seems that the general agreement is to treat until clearance and then treat for another 2 months,” Dr. Diane M. Thiboutot said.
Latest News
More than a month after launch, iPLEDGE glitches persist
The latest improvement attempt is a tool created by the Isotretinoin Products Manufacturers Group, the manufacturers responsible for the FDA-...
Latest News
FDA updates status of iPLEDGE access problems
The Isotretinoin Products Manufacturers Group has “created a new tool within the system to help resolve account access for some user groups...
Sponsored Best Practices
Antibiotic Resistance: What the Dermatologist Needs to Know
Latest News
iPLEDGE rollout: As frustration mounts, FDA agrees to help solve issues
American Academy of Dermatology Association representatives described the severe impact on patient access to treatment.
Feature
Dermatologists take to TikTok to share their own ‘hacks’
Laypeople are still the dominant producers – and have the most views – of dermatology content on TikTok.
Latest News
iPLEDGE rollout described as a failure, chaotic, and a disaster
The switch to a new platform was met with frustration from physicians, pharmacists, and patients alike.
From the Journals
International panel backs energy-based devices as first-line treatment of acne scars
A panel of 24 international experts in dermatology and plastic surgery assembled to develop the recommendations for integrating EBDs into the...
Case Letter
Acute Severe Urticaria From Minocycline
Minocycline-induced acute urticaria and anaphylaxis are rare adverse events.
Conference Coverage
Topical options for acne patients continue to expand
In 2020, clascoterone cream became the first topical androgen receptor inhibitor approved for the treatment of acne in patients aged 12 years and...